Marinus Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
MRNS
CUSIP
56854Q200
All holders as of
Q4 2024
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 56854Q200 since 12/18/2024, largest first.

Filer % of Class Filed
Suvretta Capital Management, LLC 13G
5.5% 2/11/2025
Event 2/7/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Vanguard Group Inc 13G/A 4.7% 1/31/2025
Event 12/31/2024
Tang Capital Partners LP 13G/A
3.0% 2/14/2025
Event 12/31/2024
Beryl Capital Management LLC 13G/A
0% 5/15/2025
Event 3/31/2025
Franklin Resources, Inc. 13G/A
0% 2/11/2025
Event 12/31/2024
Morgan Stanley 13G/A
0% 3/6/2025
Event 2/28/2025
Panacea Innovation Ltd 13G/A
0% 2/14/2025
Event 12/31/2024
Sofinnova Investments, Inc. 13G/A
0% 2/12/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2024 Q4 54 29.6 M $15.8M
2024 Q3 78 41.5 M $73.8M
2024 Q2 91 43.5 M $50.9M
2024 Q1 119 54.7 M $494M
2023 Q4 110 54.5 M $593M
2023 Q3 106 51.1 M $411M
2023 Q2 110 44.7 M $485M
2023 Q1 90 41.1 M $284M
2022 Q4 75 40.6 M $166M
2022 Q3 70 28.9 M $187M
2022 Q2 74 28.8 M $141M
2022 Q1 85 30.0 M $281M
2021 Q4 77 30.0 M $357M
2021 Q3 84 31.8 M $362M
2021 Q2 81 31.5 M $563M
2021 Q1 88 31.9 M $493M
2020 Q4 90 29.8 M $363M
2020 Q3 76 18.6 M $239M